Mario Schlosser Sells 286,182 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) insider Mario Schlosser sold 286,182 shares of the company’s stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $15.27, for a total value of $4,369,999.14. Following the transaction, the insider directly owned 501,148 shares of the company’s stock, valued at approximately $7,652,529.96. This represents a 36.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Mario Schlosser also recently made the following trade(s):

• On Monday, September 22nd, Mario Schlosser sold 395,000 shares of Oscar Health stock. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00.

Oscar Health Price Performance

OSCR stock opened at $14.09 on Thursday. The business has a 50 day moving average price of $18.51 and a 200 day moving average price of $16.91. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. The stock has a market cap of $3.73 billion, a price-to-earnings ratio of -12.58 and a beta of 1.88. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.80.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The company had revenue of $2.93 billion for the quarter, compared to analysts’ expectations of $3.09 billion. During the same quarter last year, the company earned ($0.22) earnings per share. The firm’s revenue for the quarter was up 23.2% on a year-over-year basis. Oscar Health has set its FY 2025 guidance at EPS. Equities research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on OSCR shares. Zacks Research upgraded shares of Oscar Health from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. Wells Fargo & Company reduced their target price on Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a report on Thursday, November 13th. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research note on Wednesday, October 8th. Piper Sandler cut their price target on Oscar Health from $14.00 to $13.00 and set a “neutral” rating on the stock in a research report on Thursday, August 14th. Finally, Wall Street Zen downgraded Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, August 9th. Six research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average price target of $13.14.

Hedge Funds Weigh In On Oscar Health

Several institutional investors have recently added to or reduced their stakes in OSCR. Farther Finance Advisors LLC lifted its position in Oscar Health by 4,420.7% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock worth $25,000 after acquiring an additional 1,282 shares during the period. LRI Investments LLC lifted its holdings in shares of Oscar Health by 377.9% during the second quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock worth $26,000 after purchasing an additional 975 shares during the period. Jones Financial Companies Lllp grew its position in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares during the last quarter. Strs Ohio purchased a new position in Oscar Health in the 1st quarter valued at $30,000. Finally, Larson Financial Group LLC increased its stake in Oscar Health by 83,733.3% in the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock valued at $33,000 after buying an additional 2,512 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.